Scarica l'app Stockscreener
196.80
1.53%
-3.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$199.85
Aprire:
$201.35
Volume 24 ore:
3.13M
Relative Volume:
1.58
Capitalizzazione di mercato:
$46.09B
Reddito:
$250.74B
Utile/perdita netta:
$1.55B
Rapporto P/E:
30.09
EPS:
6.5398
Flusso di cassa netto:
$4.39B
1 W Prestazione:
-1.93%
1M Prestazione:
-2.97%
6M Prestazione:
-7.28%
1 anno Prestazione:
+27.80%
Intervallo 1D:
$196.20
$201.51
Intervallo di 1 settimana:
$196.20
$201.89
Portata 52W:
$137.75
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
196.80 | 46.81B | 250.74B | 1.55B | 4.39B | 6.5398 |
MCK
Mckesson Corp
|
742.44 | 90.99B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
269.36 | 52.09B | 328.68B | 2.55B | 1.56B | 13.03 |
HSIC
Henry Schein Inc
|
76.58 | 8.69B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
1.52 | 1.32B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health Inc. stock (US14149Y1082): Insider activity in focus as shares hover around USD 200 - AD HOC NEWS
Cardinal Health Inc. stock underperforms Friday when compared to competitors - MarketWatch
Cardinal Health Inc. stock (US14149Y1082): steady trading as investors digest recent guidance and va - AD HOC NEWS
Cardinal Health Inc. stock (US14149Y1082): earnings momentum and healthcare distribution in focus - AD HOC NEWS
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy? - TradingView
Is Cardinal Health (CAH) a Great Value Stock Right Now? - Yahoo Finance Singapore
Cardinal Health (CAH) Valuation Check After Recent Sideways Share Performance - Yahoo Finance
CAH Stock Price, Quote & Chart | CARDINAL HEALTH INC (NYSE:CAH) - ChartMill
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): Analyst target cut meets steady dividend story - AD HOC NEWS
Cardinal Health, Inc. (CAH) Stock Analysis: Unveiling a 22% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Cardinal Health Inc. stock (US14149Y1082): Dividend move and healthcare distribution in focus - AD HOC NEWS
Spotting Winners: Cardinal Health (NYSE:CAH) And Healthcare Providers & Services Stocks In Q1 - Yahoo Finance
Precision Trading with Cardinal Health Inc. (CAH) Risk Zones - Stock Traders Daily
Cardinal Health stock (US14149Y1082): focus on cost cuts and pharma growth after latest quarterly re - AD HOC NEWS
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - Yahoo Finance
Possible Bearish Signals With Cardinal Health Insiders Disposing Stock - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): shares react to Q3 2026 earnings beat - AD HOC NEWS
Cardinal Health Inc. stock (US14149Y1082): steady gains and healthcare exposure for US investors - AD HOC NEWS
Is CAH Becoming the Backbone of US Healthcare Infrastructure? - TradingView
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy? - Eastern Progress
Which Is a Better Investment, BrightSpring Health Services, Inc. or Cardinal Health, Inc. Stock? - AAII
Daily Brief Health Care: Dermavon Holdings, Alebund Pharmaceuticals Jiangsu, Alnylam Pharmaceuticals, Artrya , Bavarian Nordic A/S, Cardinal Health, Dexcom Inc, American Shared Hospital Servi, Eli Lilly & Co, Abeona Therapeutics and more - Smartkarma
Cardinal Health stock (US14149Y1082): dividend hike and higher FY2026 outlook - AD HOC NEWS
Cardinal Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Top Companies Driving Innovation In Specimen Bag Zip Closure Solutions - SNS Insider
CAH Technical Analysis | Trend, Signals & Chart Patterns | CARDINAL HEALTH INC (NYSE:CAH) - ChartMill
Cardinal Health Inc. stock (US14149Y1082): dividend hike and higher FY2026 guidance in focus - AD HOC NEWS
Cardinal Health dividend preview: strong Q3 earnings point to May payout boost - MSN
Why is Cardinal Health stock sinking Thursday? - MSN
Cardinal Health (CAH) Is Up 6.3% After Raising 2026 EPS Outlook and Trimming Tax Guidance - Sahm
Cardinal Health Is One of the S&P 500’s Biggest Decliners Today. A Guidance Hike Didn’t Matter. - Barron's
Does Cardinal Health's (CAH) Higher Dividend and Guidance Hint at a New Capital Allocation Play? - Yahoo Finance
Cardinal Health Inc. stock (US14149Y1082): EPS beat contrasts with recent share-price weakness - AD HOC NEWS
Do options traders know something about Cardinal Health stock we don't? - MSN
Cardinal Health Inc. stock (US14149Y1082): earnings beat meets fresh momentum signal - AD HOC NEWS
Cardinal Health Inc (CAH) Stock Up 4.3% but GF Value Says Overva - GuruFocus
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell? - TradingView
Cardinal Health stock (US14149Y1082): Beats Q3 Earnings, Analysts Trim Price Targets - AD HOC NEWS
Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It? - Yahoo Finance
BofA Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $240 - Moomoo
Baird Keeps Outperform on Cardinal Health (CAH) Following Earnings Update - Insider Monkey
Cardinal Health Inc stock (US14149Y1082): Recent earnings beat highlights strong performance - AD HOC NEWS
Transcript : Cardinal Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment? - TradingView
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Dexcom (DXCM) - The Globe and Mail
Cardinal Health (CAH) Valuation Check As Income Drop And Goodwill Impairment Pressure The Story - Sahm
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health Extends Beyond Distribution With Surgical Case Cart Automation - Yahoo Finance
Cardinal Health's (NYSE:CAH) Earnings Offer More Than Meets The Eye - Moomoo
We Think Cardinal Health's (NYSE:CAH) Solid Earnings Are Understated - Yahoo Finance
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.62%
1.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):